Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,991 total articles

ATN International, Inc. Completes Initial Closing on the Sale of its Towers and Updates 2026 Outlook

ATN International, Inc. Completes Initial Closing on the Sale of its Towers and Updates 2026 Outlook

ATN International, Inc. announced the initial closing of its $268 million sale of Southwestern U.S. towers to Everest Infrastructure Partners. Proceeds will strengthen liquidity and reduce debt. The sale is expected to lower 2026 revenue, operating income, and Adjusted EBITDA, causing the firm to revise its 2026 Adjusted EBITDA guidance downward to…

Xos Launches the 2.5MWh Power Hub, Delivering Grid-Independent Energy Storage to Data Centers in Days, Not Years

Xos Launches the 2.5MWh Power Hub, Delivering Grid-Independent Energy Storage to Data Centers in Days, Not Years

Xos, Inc. has introduced the 2.5MWh Power Hub series, a factory-integrated, rapidly deployable energy storage and hybrid power system designed to deliver megawatt-scale power within days, bypassing traditional 3 to 7 year US grid interconnection delays. Built on a proven platform with over 250 MWh deployed across North America, the Power Hub target…

Crescent Biopharma to Present at June Investor Conferences

Crescent Biopharma to Present at June Investor Conferences

Crescent Biopharma, a clinical-stage biotechnology company focused on cancer therapies, announced that its management will present at the 2026 Jefferies Global Healthcare Conference and the Goldman Sachs 47th Annual Global Healthcare Conference in June 2026. The presentations will be webcast live and replayed on the company's investor website.

Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities

Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities

Crinetics Pharmaceuticals, a US-based biotech firm specializing in endocrine disorders, has launched 'Everyday Advocacy,' a patient-centered program providing education, support, and tools to empower individuals with endocrine and related conditions. Developed in collaboration with leading patient organizations, the initiative aims to improve patie…

Netskope Joins Anthropic’s Project Glasswing

Netskope Joins Anthropic’s Project Glasswing

Netskope (NASDAQ: NTSK) has joined Anthropic's Project Glasswing, leveraging Anthropic’s advanced AI model, Mythos Preview, to detect vulnerabilities in code swiftly and at scale. This collaboration enhances Netskope's ability to provide real-time governance and security across AI applications and enterprise traffic, addressing critical gaps in AI …

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults

Vaxcyte, Inc. announced the dosing of the first participant in its Phase 1 clinical trial evaluating VAX-A1, a novel vaccine candidate designed to prevent diseases caused by Group A Streptococcus (Group A Strep). This dose-escalation study aims primarily to assess safety and tolerability, with secondary evaluation of immune response in healthy adul…

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution

Cue Biopharma announced key changes to its board of directors as part of its strategic evolution toward becoming a late-stage clinical company. Four independent directors resigned, and the company appointed Daniel Camardo, an experienced CEO with commercial launch success, and Viola Meehan, a seasoned CFO with extensive finance and governance exper…

BriaCell Therapeutics Announces Closing of Offering

BriaCell Therapeutics Announces Closing of Offering

BriaCell Therapeutics Corp., a clinical-stage biotechnology company focused on cancer immunotherapies, announced the closing of a best-efforts offering of approximately 1.45 million common shares at $3.25 per share, raising gross proceeds of about $4.7 million. The funds will be used for working capital, general corporate purposes, and advancing bu…

Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data

Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data

Syndax Pharmaceuticals showcased new data at ASCO 2026 demonstrating favorable outcomes for Revuforj (revumenib) as maintenance therapy post hematopoietic stem cell transplant in patients with high-risk acute leukemias. The pooled analysis of 24 patients revealed a 90% two-year overall survival, nearly doubling the historical benchmark of 51%. Addi…

PDF Solutions® Announces PDF Solutions CONNECT 2026 Conference

PDF Solutions® Announces PDF Solutions CONNECT 2026 Conference

PDF Solutions, Inc. has announced it will host its CONNECT 2026 conference on October 15-16, 2026, in San Francisco, focusing on AI-driven analytics and collaboration in semiconductor manufacturing. The event will feature keynotes, demos, and presentations highlighting advancements in AI platforms that enable scalable, data-driven solutions for nex…

J-Star Holding Outlines Foundational Milestones Supporting Proposed Baytown Battery Manufacturing Facility

J-Star Holding Outlines Foundational Milestones Supporting Proposed Baytown Battery Manufacturing Facility

J-Star Holding announced significant progress for its proposed $122.5 million solid-state battery manufacturing facility in Baytown, Texas, including Taiwan Central Bank authorization for $60 million outbound investment and a formal site commitment from Baytown West Chambers County Economic Development Foundation. These developments enhance capital…